Literature DB >> 18395366

Coordinated expression of clustered cancer/testis genes encoded in a large inverted repeat DNA structure.

Anne Bredenbeck1, Verena M Hollstein, Uwe Trefzer, Wolfram Sterry, Peter Walden, Florian O Losch.   

Abstract

Cancer/testis antigens (CTA) are expressed in cancers and testis or placenta only and, therefore are considered promising targets for cancer immunotherapy and diagnosis. One family of CTA is the MAGEA family which comprises 13 members and was shown to be expressed synchronously with members from the CSAG (TRAG-3) family of CTA. The MAGEA genes are arranged in 4 subclusters located on the X chromosome. Subcluster III exposes a remarkable gene organization with an inverted repeat (IR) DNA structure of a triplicated couplet of a MAGEA gene and a CSAG gene. Analyzing the mRNA expression pattern of all genes of the MAGEA and CSAG family of cancer/testis genes, we show that the MAGEA and CSAG genes encoded in the large IR are expressed coordinately and independent from the MAGEAs encoded outside the IR. These results reinforce our hypothesis that the large MAGEA/CSAG-IR DNA structure has an impact on the regulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395366     DOI: 10.1016/j.gene.2008.02.019

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.

Authors:  Rachel E Beard; Daniel Abate-Daga; Shannon F Rosati; Zhili Zheng; John R Wunderlich; Steven A Rosenberg; Richard A Morgan
Journal:  Clin Cancer Res       Date:  2013-09-10       Impact factor: 12.531

2.  Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.

Authors:  Sachet A Shukla; Pavan Bachireddy; Bastian Schilling; Christina Galonska; Qian Zhan; Clyde Bango; Rupert Langer; Patrick C Lee; Daniel Gusenleitner; Derin B Keskin; Mehrtash Babadi; Arman Mohammad; Andreas Gnirke; Kendell Clement; Zachary J Cartun; Eliezer M Van Allen; Diana Miao; Ying Huang; Alexandra Snyder; Taha Merghoub; Jedd D Wolchok; Levi A Garraway; Alexander Meissner; Jeffrey S Weber; Nir Hacohen; Donna Neuberg; Patrick R Potts; George F Murphy; Christine G Lian; Dirk Schadendorf; F Stephen Hodi; Catherine J Wu
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

3.  A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.

Authors:  Nachimuthu Chinnasamy; Jennifer A Wargo; Zhiya Yu; Mahadev Rao; Timothy L Frankel; John P Riley; Jenny J Hong; Maria R Parkhurst; Steven A Feldman; David S Schrump; Nicholas P Restifo; Paul F Robbins; Steven A Rosenberg; Richard A Morgan
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

4.  Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.

Authors:  Mahadev Rao; Nachimuthu Chinnasamy; Julie A Hong; Yuwei Zhang; Mary Zhang; Sichuan Xi; Fang Liu; Victor E Marquez; Richard A Morgan; David S Schrump
Journal:  Cancer Res       Date:  2011-05-05       Impact factor: 12.701

5.  Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice.

Authors:  Matthias Obenaus; Catarina Leitão; Matthias Leisegang; Xiaojing Chen; Ioannis Gavvovidis; Pierre van der Bruggen; Wolfgang Uckert; Dolores J Schendel; Thomas Blankenstein
Journal:  Nat Biotechnol       Date:  2015-03-16       Impact factor: 54.908

6.  Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12.

Authors:  Shigui Zhu; Benoit J Van den Eynde; Pierre G Coulie; Yong F Li; Mona El-Gamil; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

7.  Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.

Authors:  Brian T Weinert; Kausilia K Krishnadath; Francesca Milano; Ayako W Pedersen; Mogens H Claesson; Mai-Britt Zocca
Journal:  Cancer Immun       Date:  2009-10-09

8.  CSAG2 is a cancer-specific activator of SIRT1.

Authors:  Xu Yang; Patrick Ryan Potts
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

9.  Pharmacogenomic approach to identify drug sensitivity in small-cell lung cancer.

Authors:  Gary Wildey; Yanwen Chen; Ian Lent; Lindsay Stetson; John Pink; Jill S Barnholtz-Sloan; Afshin Dowlati
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

10.  Wavelet analysis of DNA walks on the human and chimpanzee MAGE/CSAG-palindromes.

Authors:  Yanjiao Qi; Nengzhi Jin; Duiyuan Ai
Journal:  Genomics Proteomics Bioinformatics       Date:  2012-08-06       Impact factor: 7.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.